Approval · Notice of Compliance 9996 · 2009
ALVESCO: Notice of Compliance 9996
Issued January 15, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9996
- Date
- January 15, 2009
- Company
- Nycomed Canada IncOakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Extended indication: prophylactic management of steroid-responsive bronchial asthma in children 6-11 years of age
- Therapeutic class
- Coticosteroid for oral inhalation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALVESCO | Not yet assigned | — |
Medicinal ingredients
- CICLESONIDE 50 MCG per ACT
- CICLESONIDE 100 MCG per ACT
- CICLESONIDE 200 MCG per ACT